DSCA-HLAII: A dual-stream cross-attention model for predicting peptide–HLA class II interaction and presentation
PLOS Computational Biology · 2026
DOI: 10.1371/journal.pcbi.1013836 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Ke Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Technology, Beijing Institute of Technology, Beijing, China. Hauptthemen laut MEDLINE: Peptides, Computational Biology, Histocompatibility Antigens Class II, Antigen Presentation. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, Zhongguancun Academy.
Abstract (Originalsprache)
Motivation The interaction between peptides and human leukocyte antigen class II (HLA-II) molecules plays a pivotal role in adaptive immune responses, as HLA-II mediates the recognition of exogenous antigens and initiates T cell activation through peptide presentation. Accurate prediction of peptide-HLA-II binding serves as a cornerstone for deciphering cellular immune responses, and is essential for guiding the optimization of antibody therapeutics. Researchers have developed several computational approaches to identify peptide-HLA-II interaction and presentation. However, most computational approaches exhibit inconsistent predictive performance, poor generalization ability and limited biological interpretability. Results In this study, we present DSCA-HLAII, a novel predictive framework for peptide-HLA-II interactions and presentation based on a dual-stream cross-attention architecture. The framework proposes a dual-stream cross-attention (DSCA) mechanism to integrate pre-trained semantic embedding ESMC with sequence-level ONE-HOT features. The DSCA mechanism effectively models the interaction dynamics between peptides and HLA-II molecules, enabling the precise identification of key binding sites. Experimental results demonstrate that DSCA-HLAII consistently surpasses existing state-of-the-art approaches, demonstrating high accuracy and robustness in predicting peptide-HLA-II interactions and presentation. We further demonstrate the capability of DSCA-HLAII for predicting peptide binding cores and assessing antibody immunogenicity, which is expected to advance artificial intelligence-based peptide drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Technology, Beijing Institute of Technology, Beijing, China.
- Zhongguancun Academy, Beijing, China.
- Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
- Centre for Biomedical Research and Technology, AI and Digital Sciences Institute, Faculty of Computer Science, HSE University, Moscow, Russia.
- SMBU-MSU-BIT Joint Laboratory on Bioinformatics and Engineering Biology, Shenzhen MSU-BIT University, Shenzhen, Guangdong, China.
- Department of Thoracic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China.
ORCID-Profile: Bin Liu
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Zhongguancun Academy
- HSE basic research program
Zitieren
APA
Yan, K., Yu, H., Chen, S., Shaytan, A. K., Liu, B., & Wang, Y. (2026). DSCA-HLAII: A dual-stream cross-attention model for predicting peptide–HLA class II interaction and presentation. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013836
Vancouver
Yan K, Yu H, Chen S, Shaytan AK, Liu B, Wang Y. DSCA-HLAII: A dual-stream cross-attention model for predicting peptide–HLA class II interaction and presentation. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1013836
BibTeX
@article{Yan2026,
author = {Yan, Ke and Yu, Hongjun and Chen, Shutao and Shaytan, Alexey K and Liu, Bin and Wang, Youyu},
title = {DSCA-HLAII: A dual-stream cross-attention model for predicting peptide–HLA class II interaction and presentation},
journal = {PLOS Computational Biology},
year = {2026},
doi = {10.1371/journal.pcbi.1013836}
}
EUVIMED